[Diabetes Mellitus and Dementia]

Area of Science:

• Neuroscience
• Endocrinology
• Geriatrics

Background:

• Diabetes mellitus (DM) is a recognized risk factor for both Alzheimer's and vascular dementia.
• The precise mechanisms linking DM to neurodegeneration are not fully understood.
• Brain insulin resistance (IR) is a potential contributor to DM-related cognitive impairment.

Purpose of the Study:

• To explore the role of brain insulin resistance in diabetes-associated dementia.
• To review the potential of targeting brain IR for dementia prevention and treatment.
• To highlight the challenges in managing diabetic patients with dementia.

Main Methods:

• Literature review of existing data on diabetes, insulin resistance, and dementia.
• Analysis of the impact of glucose-lowering therapies on cognitive decline in diabetic patients.
• Examination of clinical challenges in treating diabetic patients with dementia, including hypoglycemia risk.

Main Results:

• Accumulating evidence supports DM as a risk factor for dementia.
• Brain insulin resistance is implicated in DM-related cognitive impairment.
• Limited clinical data exist on the efficacy of glucose-lowering therapies for preventing cognitive decline in older diabetic individuals.
• Diabetic patients with dementia face challenges like frailty, renal dysfunction, and poor adherence, increasing hypoglycemia risk and cognitive dysfunction.

Conclusions:

• Older diabetic patients are at high risk for dementia.
• Comprehensive and careful medical management is crucial for this population.
• Further research is warranted to elucidate DM-induced neurodegeneration and evaluate therapeutic interventions.